Market Share of Pharmacogenomics Industry
The pharmacogenomics market is highly fragmented due to several key players. The large interest of researchers and investment in the safety and efficiency of drugs by companies is the major factors responsible for the market's growth, making it highly competitive with the presence of many key players in the pharmacogenomics market. The government is also involved in funding companies that work to develop bioinformatics technology for precision medicine research applications. Some players are Abbott Laboratories Inc, Biomerieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Thermo Fisher Scientific, and F. Hoffman-La Roche Ltd, among others.
Pharmacogenomics Market Leaders
Thermo Fisher Scientific Inc.
Abbott Laboratories Inc.
F. Hoffmann-La Roche AG
Bio-Rad Laboratories
Biomerieux SA
*Disclaimer: Major Players sorted in no particular order
